Cargando…
JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis
Lung adenocarcinoma (LUAD) is the most common lung cancer, with high mortality. As a tumor-suppressor gene, JWA plays an important role in blocking pan-tumor progression. JAC4, a small molecular-compound agonist, transcriptionally activates JWA expression both in vivo and in vitro. However, the dire...
Autores principales: | Ding, Kun, Jiang, Xuqian, Wang, Zhangding, Zou, Lu, Cui, Jiahua, Li, Xiong, Shu, Chuanjun, Li, Aiping, Zhou, Jianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218353/ https://www.ncbi.nlm.nih.gov/pubmed/37240137 http://dx.doi.org/10.3390/ijms24108794 |
Ejemplares similares
-
JAC1 targets YY1 mediated JWA/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC
por: Zhai, Zurong, et al.
Publicado: (2022) -
JAC4 Protects from X-ray Radiation-Induced Intestinal Injury by JWA-Mediated Anti-Oxidation/Inflammation Signaling
por: Zhou, Yan, et al.
Publicado: (2022) -
JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling
por: Ren, Yanlin, et al.
Publicado: (2021) -
Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery
por: Ding, Kun, et al.
Publicado: (2022) -
Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma
por: Li, Guoyin, et al.
Publicado: (2022)